Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NUAI Investor Alert: New Era Energy & Digital Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified False Statements: Levi & Korsinsky

globenewswire.com
NUAI

NUAI Investor Alert: New Era Energy & Digital Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified False Statements: Levi & Korsinsky

globenewswire.com
NUAI

Enphase's Generic Risk Warnings Allegedly Failed Investors — Levi & Korsinsky, LLP

globenewswire.com
ENPH

Enphase's Generic Risk Warnings Allegedly Failed Investors — Levi & Korsinsky, LLP

globenewswire.com
ENPH

ODD Investor Alert: ODDITY Tech Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Certified False Statements: Levi & Korsinsky

globenewswire.com
ODD

ODD Investor Alert: ODDITY Tech Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Certified False Statements: Levi & Korsinsky

globenewswire.com
ODD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc. - ORIC

accessnewswire.com
ORIC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aviat Networks, Inc. - AVNW

accessnewswire.com
AVNW

Corcept presenta en el Congreso de la SGO los resultados completos del ensayo clínico ROSELLA, publicados simultáneamente en The Lancet: Lifyorli™ (relacorilant) en combinación con nab-paclitaxel prolonga la supervivencia de pacientes con cáncer...

businesswire.com
CORT

Corcept präsentiert vollständige Daten aus der zulassungsrelevanten ROSELLA-Studie im Rahmen einer Late-Breaker-Präsentation auf der SGO-Konferenz, begleitet von einer gleichzeitigen Veröffentlichung in The Lancet: Lifyorli™ (Relacorilant) Plus...

businesswire.com
CORT
View all news →